Highlights

[DPHARMA] YoY Quarter Result on 2019-03-31 [#1]

Stock [DPHARMA]: DUOPHARMA BIOTECH BHD
Announcement Date 21-May-2019
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2019
Quarter 31-Mar-2019  [#1]
Profit Trend QoQ -     0.67%    YoY -     34.16%
Quarter Report


View:


Show?  YoY % Horiz. %

Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 166,454 158,713 150,386 133,259 120,994 79,470 45,599 24.06%
  YoY % 4.88% 5.54% 12.85% 10.14% 52.25% 74.28% -
  Horiz. % 365.04% 348.06% 329.80% 292.24% 265.34% 174.28% 100.00%
PBT 23,176 17,727 18,786 13,255 11,176 9,941 12,198 11.28%
  YoY % 30.74% -5.64% 41.73% 18.60% 12.42% -18.50% -
  Horiz. % 190.00% 145.33% 154.01% 108.67% 91.62% 81.50% 100.00%
Tax -5,562 -4,166 -4,321 -2,608 -2,558 -2,113 -3,229 9.48%
  YoY % -33.51% 3.59% -65.68% -1.95% -21.06% 34.56% -
  Horiz. % 172.25% 129.02% 133.82% 80.77% 79.22% 65.44% 100.00%
NP 17,614 13,561 14,465 10,647 8,618 7,828 8,969 11.89%
  YoY % 29.89% -6.25% 35.86% 23.54% 10.09% -12.72% -
  Horiz. % 196.39% 151.20% 161.28% 118.71% 96.09% 87.28% 100.00%
NP to SH 17,614 13,561 14,465 10,782 8,618 7,843 8,969 11.89%
  YoY % 29.89% -6.25% 34.16% 25.11% 9.88% -12.55% -
  Horiz. % 196.39% 151.20% 161.28% 120.21% 96.09% 87.45% 100.00%
Tax Rate 24.00 % 23.50 % 23.00 % 19.68 % 22.89 % 21.26 % 26.47 % -1.62%
  YoY % 2.13% 2.17% 16.87% -14.02% 7.67% -19.68% -
  Horiz. % 90.67% 88.78% 86.89% 74.35% 86.48% 80.32% 100.00%
Total Cost 148,840 145,152 135,921 122,612 112,376 71,642 36,630 26.30%
  YoY % 2.54% 6.79% 10.85% 9.11% 56.86% 95.58% -
  Horiz. % 406.33% 396.27% 371.06% 334.73% 306.79% 195.58% 100.00%
Net Worth 635,424 540,662 496,410 206,429 463,071 457,492 205,045 20.72%
  YoY % 17.53% 8.91% 140.47% -55.42% 1.22% 123.12% -
  Horiz. % 309.89% 263.68% 242.10% 100.68% 225.84% 223.12% 100.00%
Dividend
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Net Worth 635,424 540,662 496,410 206,429 463,071 457,492 205,045 20.72%
  YoY % 17.53% 8.91% 140.47% -55.42% 1.22% 123.12% -
  Horiz. % 309.89% 263.68% 242.10% 100.68% 225.84% 223.12% 100.00%
NOSH 706,026 684,383 661,881 278,959 278,959 278,959 139,486 31.00%
  YoY % 3.16% 3.40% 137.27% 0.00% 0.00% 99.99% -
  Horiz. % 506.16% 490.64% 474.51% 199.99% 199.99% 199.99% 100.00%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin 10.58 % 8.54 % 9.62 % 7.99 % 7.12 % 9.85 % 19.67 % -9.81%
  YoY % 23.89% -11.23% 20.40% 12.22% -27.72% -49.92% -
  Horiz. % 53.79% 43.42% 48.91% 40.62% 36.20% 50.08% 100.00%
ROE 2.77 % 2.51 % 2.91 % 5.22 % 1.86 % 1.71 % 4.37 % -7.31%
  YoY % 10.36% -13.75% -44.25% 180.65% 8.77% -60.87% -
  Horiz. % 63.39% 57.44% 66.59% 119.45% 42.56% 39.13% 100.00%
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
RPS 23.58 23.19 22.72 47.77 43.37 28.49 32.69 -5.29%
  YoY % 1.68% 2.07% -52.44% 10.15% 52.23% -12.85% -
  Horiz. % 72.13% 70.94% 69.50% 146.13% 132.67% 87.15% 100.00%
EPS 2.49 1.98 2.19 3.82 3.43 2.81 6.43 -14.61%
  YoY % 25.76% -9.59% -42.67% 11.37% 22.06% -56.30% -
  Horiz. % 38.72% 30.79% 34.06% 59.41% 53.34% 43.70% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.9000 0.7900 0.7500 0.7400 1.6600 1.6400 1.4700 -7.84%
  YoY % 13.92% 5.33% 1.35% -55.42% 1.22% 11.56% -
  Horiz. % 61.22% 53.74% 51.02% 50.34% 112.93% 111.56% 100.00%
Adjusted Per Share Value based on latest NOSH - 941,765
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
RPS 17.67 16.85 15.97 14.15 12.85 8.44 4.84 24.06%
  YoY % 4.87% 5.51% 12.86% 10.12% 52.25% 74.38% -
  Horiz. % 365.08% 348.14% 329.96% 292.36% 265.50% 174.38% 100.00%
EPS 1.87 1.44 1.54 1.14 0.92 0.83 0.95 11.94%
  YoY % 29.86% -6.49% 35.09% 23.91% 10.84% -12.63% -
  Horiz. % 196.84% 151.58% 162.11% 120.00% 96.84% 87.37% 100.00%
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.6747 0.5741 0.5271 0.2192 0.4917 0.4858 0.2177 20.73%
  YoY % 17.52% 8.92% 140.47% -55.42% 1.21% 123.15% -
  Horiz. % 309.92% 263.71% 242.12% 100.69% 225.86% 223.15% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Date 31/03/21 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 31/03/15 -
Price 2.7500 1.3900 1.2800 2.8000 2.3100 2.5500 3.8800 -
P/RPS 11.66 5.99 5.63 5.86 5.33 8.95 11.87 -0.30%
  YoY % 94.66% 6.39% -3.92% 9.94% -40.45% -24.60% -
  Horiz. % 98.23% 50.46% 47.43% 49.37% 44.90% 75.40% 100.00%
P/EPS 110.23 70.15 58.57 72.44 74.77 90.70 60.34 10.55%
  YoY % 57.13% 19.77% -19.15% -3.12% -17.56% 50.31% -
  Horiz. % 182.68% 116.26% 97.07% 120.05% 123.91% 150.31% 100.00%
EY 0.91 1.43 1.71 1.38 1.34 1.10 1.66 -9.53%
  YoY % -36.36% -16.37% 23.91% 2.99% 21.82% -33.73% -
  Horiz. % 54.82% 86.14% 103.01% 83.13% 80.72% 66.27% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 3.06 1.76 1.71 3.78 1.39 1.55 2.64 2.49%
  YoY % 73.86% 2.92% -54.76% 171.94% -10.32% -41.29% -
  Horiz. % 115.91% 66.67% 64.77% 143.18% 52.65% 58.71% 100.00%
Price Multiplier on Announcement Date
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Date 03/05/21 - 21/05/19 28/05/18 22/05/17 18/05/16 18/05/15 -
Price 2.9300 1.7200 1.3600 3.3500 2.3200 2.4000 3.9000 -
P/RPS 12.43 7.42 5.99 7.01 5.35 8.42 11.93 0.69%
  YoY % 67.52% 23.87% -14.55% 31.03% -36.46% -29.42% -
  Horiz. % 104.19% 62.20% 50.21% 58.76% 44.84% 70.58% 100.00%
P/EPS 117.44 86.80 62.23 86.67 75.10 85.36 60.65 11.63%
  YoY % 35.30% 39.48% -28.20% 15.41% -12.02% 40.74% -
  Horiz. % 193.64% 143.12% 102.61% 142.90% 123.83% 140.74% 100.00%
EY 0.85 1.15 1.61 1.15 1.33 1.17 1.65 -10.46%
  YoY % -26.09% -28.57% 40.00% -13.53% 13.68% -29.09% -
  Horiz. % 51.52% 69.70% 97.58% 69.70% 80.61% 70.91% 100.00%
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 3.26 2.18 1.81 4.53 1.40 1.46 2.65 3.51%
  YoY % 49.54% 20.44% -60.04% 223.57% -4.11% -44.91% -
  Horiz. % 123.02% 82.26% 68.30% 170.94% 52.83% 55.09% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


FEATURED POSTS

1. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Health minister: Traveller from South Africa on Nov 19 is Malaysia’s first Omicron case save malaysia!
2. WHO urges Asia-Pacific to ready for Omicron-driven surge in infections Good Articles to Share
3. The case of ATA IMS: A tip of the iceberg? By Veeriah save malaysia!
4. Latest Land Disposal in Sg Tiram, Johor, shows Palm Oil Companies with Huge Landbanks with Cheap Book Value are Jewels, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
5. MIDF Research maintains 'buy' recommendation on FGV, target price unchanged at RM2.20 (FANTASTIC: ALL PALM OIL STOCKS SHOULD RE RERATED, Calvin Tan THE INVESTMENT APPROACH OF CALVIN TAN
6. Aurelius Technologies Bhd - Global EMS Provider PublicInvest Research
7. 3QCY21 Results Review - Fat Tails Kenanga Research & Investment
8. Strategy - A decent 3Q2021 but uncertainty has increased AmInvest Research Reports
APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Stock Screener using Technical and Fundamental criteria
MQ Affiliate
Join the MQ Affiliate Program today to earn rewards
 
 

362  474  546  892 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VSOLAR 0.015-0.005 
 VS 1.15-0.27 
 THHEAVY 0.015-0.05 
 VS-WB 0.355-0.09 
 IMPIANA 0.085+0.005 
 INARI 3.87-0.23 
 GOCEAN 0.0350.00 
 DNEX 0.745-0.025 
 ATAIMS 0.445+0.035 
 EAH 0.02+0.005 
PARTNERS & BROKERS